Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
1,041.40
-7.35 (-0.7%)
BSENSE

Nov 20

BSE+NSE Vol: 2.04 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 807696,
    "name": "Alembic Pharma",
    "stock_name": "Alembic Pharma",
    "full_name": "Alembic Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/alembic-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,041.40",
    "chg": -7.35,
    "chgp": "-0.7%",
    "dir": -1,
    "prev_price": "1,048.75",
    "mcapval": "20,571.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 533573,
    "symbol": "APLLTD",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE901L01018",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.04 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/alembic-pharma-807696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Alembic Pharmaceuticals Ltd. to 52-Week High of Rs 1053",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1053-4256496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlembicPharmace_priceRelatedfactors_4256496.png",
        "date": "2026-11-09 09:48:22",
        "description": "With a decisive break above Rs 1050, Alembic Pharmaceuticals Ltd. has reached a fresh 52-week high on 09 Nov 2026, marking a significant milestone in its price momentum. This surge comes amid a three-day winning streak that has propelled the stock up by 17.1%, outpacing its sector by nearly 4% today alone."
      },
      {
        "title": "Alembic Pharmaceuticals Surges 21.06% in a Week: Key Drivers Behind the Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alembic-pharmaceuticals-surges-2106-in-a-week-key-drivers-behind-the-rally-4255486",
        "imagepath": "",
        "date": "2026-11-07 15:04:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Technical momentum shifts signal mild bullish outlook</p>\n                    <p><strong>4 Nov:</strong> Intraday surge of 13.65% to Rs.914.7</p>\n                    <p><strong>5 Nov:</strong> Strong quarterly growth reported; Mojo Grade upgraded to Buy</p>\n                    <p><strong>6 Nov:</strong> New 52-week high of Rs.971.4 and quality upgrade to Strong Buy</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.797.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs..."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Hits New 52-Week High of Rs 971.4 on Back of Strong Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-reaches-new-52-week-high-of-rs9714-4254275",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlembicPharmace_priceRelatedfactors_4254275.png",
        "date": "2026-11-06 12:11:40",
        "description": "A surge to Rs 971.4 today marked a fresh 52-week high for Alembic Pharmaceuticals Ltd., reflecting a robust technical momentum that has propelled the stock well above its key moving averages and outpaced its sector peers."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Surges 7.62% to Day's High of Rs 971.4 — Outperforms Sector by 7.45 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-hits-intraday-high-with-762-surge-on-6-nov-2026-4254224",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlembicPharmace_priceRelatedfactors_4254224.png",
        "date": "2026-11-06 11:46:29",
        "description": "The Sensex advanced 0.57% on 06 Nov 2026, yet Alembic Pharmaceuticals Ltd. outpaced the broader market with a robust 7.62% gain, touching an intraday high of Rs 971.4. This 7.45 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4251421",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlembicPharmace_technicaldot_4251421.png",
        "date": "2026-11-05 08:04:33",
        "description": "Alembic Pharmaceuticals Ltd. has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMojo Mojo Grade from Hold to Buy. The stock’s recent surge of 12.81% in a single day reflects renewed investor confidence, underpinned by positive signals from MACD, moving averages, and Bollinger Bands, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Reports Strong Quarterly Growth, Upgrades to Buy",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-reports-strong-quarterly-growth-upgrades-to-buy-4251125",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlembicPharmace_fintrenddot_4251125.png",
        "date": "2026-11-05 08:00:36",
        "description": "Alembic Pharmaceuticals Ltd. has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, prompting an upgrade in its Mojo Grade from Hold to Buy. The company’s robust revenue growth, margin expansion, and operational efficiency have contributed to this positive shift, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Surges 13.65% to Day's High of Rs 914.7 — Outperforms Sector by 13.46 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-hits-intraday-high-with-1365-surge-on-4-nov-2026-4250920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlembicPharmace_priceRelatedfactors_4250920.png",
        "date": "2026-11-04 14:38:08",
        "description": "The Sensex rose 0.37% on 04 Nov 2026, but Alembic Pharmaceuticals Ltd. outpaced the broader market with a remarkable 13.65% gain, touching an intraday high of Rs 914.7. This 13.46 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-4245397",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AlembicPharmace_mojoScore_4245397.png",
        "date": "2026-10-31 10:10:24",
        "description": "Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4238258",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AlembicPharmace_technicaldot_4238258.png",
        "date": "2026-10-26 08:01:57",
        "description": "Alembic Pharmaceuticals Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these technical parameters in detail, placing the stock’s performance in the context of broader market trends and sector dynamics."
      }
    ],
    "total": 69,
    "sid": "807696",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/alembic-pharmaceuticals-807696"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "14-Nov-2026",
      "details": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets 15 mg and 45 mg.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "10-Nov-2026",
      "details": "Please find attached herewith the Transcript of Post Results Conference Call held on 4th November 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Nov-2026",
      "details": "Please find attached Newspaper Publication related to Unaudited Financial Results of the Company for the quarter ended 30th September 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alembic Pharmaceuticals Ltd. has declared <strong>600%</strong> dividend, ex-date: 29 Jul 26",
          "dt": "2026-07-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

14-Nov-2026 | Source : BSE

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets 15 mg and 45 mg.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

10-Nov-2026 | Source : BSE

Please find attached herewith the Transcript of Post Results Conference Call held on 4th November 2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Nov-2026 | Source : BSE

Please find attached Newspaper Publication related to Unaudited Financial Results of the Company for the quarter ended 30th September 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alembic Pharmaceuticals Ltd. has declared 600% dividend, ex-date: 29 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available